Machines with a workbench
An enzyme is a protein that speeds up a specific chemical reaction — turning one molecule (the substrate) into another (the product) thousands of times faster than it would happen on its own. The reaction takes place in a precisely shaped cleft called the active site, the enzyme's workbench. Because each enzyme runs one step of the body's chemistry, blocking one is a clean way to stop that step on purpose.
Two enzyme families show up constantly in drug discovery. A kinase tags other proteins with a phosphate group to switch them on or off — a master controller of cell signalling, and a huge target class in cancer. A protease cuts other proteins at specific points like molecular scissors; proteases are central targets in viruses, blood clotting and inflammation. When you meet a new enzyme target, asking "is it a kinase or a protease?" already tells you much of its story.
Inhibition: jamming the workbench
Most enzyme drugs are inhibitors: they slow or stop the enzyme. The commonest way is competitive inhibition, where the drug sits in the active site itself and competes with the natural substrate for the same spot. Whoever gets there first holds it; flood the system with enough drug and the substrate is shut out. Because the contest is about who occupies the slot, a competitive inhibitor that resembles the substrate's shape is often a great starting design.
How well an inhibitor works is captured by two numbers you'll see everywhere. The inhibition constant (Ki) measures how tightly it binds — smaller is stronger. The IC50 is the concentration that cuts the enzyme's activity in half — again, smaller means more potent. Both shrink as your molecule improves, so watching them fall across a series of compounds is how a chemist sees progress.
From bench to medicine
The statin family is the textbook success story: each one is a competitive inhibitor of the enzyme that makes cholesterol, and together they have reshaped cardiovascular medicine. Some inhibitors go further and form a permanent chemical bond to the active site — a covalent inhibitor — so the enzyme stays switched off until the cell makes a fresh copy. Covalent inhibitors can be extremely potent and long-lasting, but they demand extra care about selectivity, since a reactive group can latch onto the wrong protein too.